“Chemical warfare agents remain a significant and continuing threat to military forces,” according to a newly updated manual jointly issued by the Army, Navy, Air Force and Marine Corps.
Islamic State fighters in Iraq set fire to a chemical factory south of Mosul, Pentagon spokesmen said last week, generating a cloud of sulfur dioxide that passed over a U.S. base in the region. (“Islamic State Burns Sulfur Stocks Near Mosul, Creating Hazard for Troops, Locals,” Wall Street Journal, October 22.)
“Sulfur dioxide is injurious to the eyes and to the respiratory tract, where it acts primarily as a central pulmonary toxicant at low to moderate doses, but may also exhibit peripheral effects (pulmonary edema) at high doses,” explained the newly released manual, which also discussed protection, diagnosis and treatment for SO2 exposure. See Multi-Service Tactics, Techniques and Procedures for Treatment of Chemical Warfare Agent Casualties and Conventional Military Chemical Injuries, ATP 4-02.85, August 2016.
Another new Pentagon publication described the role of the role of the U.S. military in responding to, and mitigating, the effects of unconventional weapons and hazardous materials, whether induced deliberately or accidentally. See Chemical, Biological, Radiological, and Nuclear Response, Joint Publication 3-41, September 9, 2016.
Using the NIST as an example, the Radiation Physics Building (still without the funding to complete its renovation) is crucial to national security and the medical community. If it were to go down (or away), every medical device in the United States that uses radiation would be decertified within 6 months, creating a significant single point of failure that cannot be quickly mitigated.
The federal government can support more proactive, efficient, and cost-effective resiliency planning by certifying predictive models to validate and publicly indicate their quality.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.